These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8537140)

  • 21. [Penetration of cefixime in the anterior chamber of the human eye].
    Tod B; Chaine G; Oliary J; Mezzanotte F; Tod M; Petitjean O
    J Fr Ophtalmol; 1991; 14(8-9):477-80. PubMed ID: 1779118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical studies of cefixime granules in pediatrics].
    Nakazawa S; Sato H; Narita A; Nakazawa S; Suzuki H; Matsumoto K; Chikaoka H; Kamigaki M; Koido R; Niino K
    Jpn J Antibiot; 1986 Apr; 39(4):1020-34. PubMed ID: 3761535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
    Westblom TU; Gudipati S; Midkiff BR
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):691-3. PubMed ID: 2226500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children.
    Memon IA; Billoo AG; Memon HI
    South Med J; 1997 Dec; 90(12):1204-7. PubMed ID: 9404906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP; Gelfand MS; Grogan J; Craft B
    Diagn Microbiol Infect Dis; 1995; 22(1-2):155-7. PubMed ID: 7587031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefixime in the treatment of respiratory and urinary tract infections.
    Ludwig E
    Chemotherapy; 1998 Sep; 44 Suppl 1():31-4. PubMed ID: 9797422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefixime, in-vitro activity, pharmacokinetics and tissue penetration.
    Stone JW; Linong G; Andrews JM; Wise R
    J Antimicrob Chemother; 1989 Feb; 23(2):221-8. PubMed ID: 2708180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms.
    Eric-Jovanovic S; Agbaba D; Zivanov-Stakic D; Vladimirov S
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):893-8. PubMed ID: 9919994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity and clinical evaluation of cefixime in urinary tract infection.
    Asvanich K; Fugpholngam V; Srimuang S; Tanphaichitra D
    J Med Assoc Thai; 1998 Apr; 81(4):301-4. PubMed ID: 9623027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone.
    Bhutta ZA; Khan IA; Molla AM
    Pediatr Infect Dis J; 1994 Nov; 13(11):990-4. PubMed ID: 7845753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.
    Markham A; Brogden RN
    Drugs; 1995 Jun; 49(6):1007-22. PubMed ID: 7641600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential therapy with intravenous and oral cephalosporins.
    Janknegt R; van der Meer JW
    J Antimicrob Chemother; 1994 Jan; 33(1):169-77. PubMed ID: 8157558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
    Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G
    Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro comparative effect of cefixime and 7 other beta-lactamines against Streptococcus pneumoniae].
    Boussougant Y; Weber P
    Presse Med; 1989 Oct; 18(32):1553-5. PubMed ID: 2530530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg].
    Montay G; Le Liboux A; Thebault JJ; Roche G; Frydman A; Gaillot J
    Presse Med; 1989 Oct; 18(32):1583-6. PubMed ID: 2530537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis.
    Friedland LR; Kulick RM; Biro FM; Patterson A
    Ann Emerg Med; 1996 Mar; 27(3):299-304. PubMed ID: 8599487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biliary excretion and hepatic disposal of cefixime: experimental and clinical study].
    Westphal JF; Brogard JM; Jehl F; Blickle JF; Dorner M; Monteil H
    Pathol Biol (Paris); 1992 May; 40(5):538-44. PubMed ID: 1495841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection.
    Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA
    J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An experimental study of cefixime in the treatment of Streptococcus pneumoniae otitis media.
    Magit AE; Dolitsky JN; Doyle WJ; Swarts JD; Seroky JT; Rosenfeld RM
    Int J Pediatr Otorhinolaryngol; 1994 Mar; 29(1):1-9. PubMed ID: 8169042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.